SynthesisDrug design, development and therapy2018

Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: a meta-analysis of published trials.

Yongping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.